X
New Huntington’s drug granted priority designation
https://pharmaphorum.com/news/huntingtons-drug-granted-priority-designation/
Roche
Roche to file Tecentriq in triple negative breast cancer
No other immunotherapies are approved in indication
Roche drug too pricey in progressive MS, says NICE
Ocrevus is effective but too pricey in PPMS, says NICE
NICE okays Roche rare lung cancer drug after price cut
Alecensa has aced Pfizer’s rival in head-to-head trial
